Analyzing CD133 and ALDH activity, Akunuru et al. separated cancer stem/progenitor cells (CD133+, ALDHhigh) from non-CSCs (CD133− or ALDHlow) and showed that non-CSCs can interconvert into CSCs. Here, PROM1 is linked to cancer.